The World Heart Federation Global Study on COVID-19 and Cardiovascular Disease
Karen Sliwa, Kavita Singh, Lana Raspail, Dike Ojji, Carolyn S P Lam, Friedrich Thienemann, Junbo Ge, Amitava Banerjee, L Kristin Newby, Antonio Luiz P Ribeiro, Samuel Gidding, Fausto Pinto, Pablo Perel, Dorairaj Prabhakaran, Karen Sliwa, Kavita Singh, Lana Raspail, Dike Ojji, Carolyn S P Lam, Friedrich Thienemann, Junbo Ge, Amitava Banerjee, L Kristin Newby, Antonio Luiz P Ribeiro, Samuel Gidding, Fausto Pinto, Pablo Perel, Dorairaj Prabhakaran
Abstract
Background: The emergence of novel coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), has presented an unprecedented global challenge for the healthcare community. The ability of SARS-CoV-2 to get transmitted during the asymptomatic phase, and its high infectivity have led to the rapid transmission of COVID-19 beyond geographic regions facilitated by international travel, leading to a pandemic. To guide effective control and interventions, primary data is required urgently, globally, including from low- and middle-income countries where documentation of cardiovascular manifestations and risk factors in people hospitalized with COVID-19 is limited.
Objectives: This study aims to describe the cardiovascular manifestations and cardiovascular risk factors in patients hospitalized with COVID-19.
Methods: We propose to conduct an observational cohort study involving 5000 patients recruited from hospitals in low-, middle- and high-income countries. Eligible adult COVID-19 patients will be recruited from the participating hospitals and followed-up until 30 days post admission. The outcomes will be reported at discharge and includes the need of ICU admission, need of ventilator, death (with cause), major adverse cardiovascular events, neurological outcomes, acute renal failure, and pulmonary outcomes.
Conclusion: Given the enormous burden posed by COVID-19 and the associated severe prognostic implication of CVD involvement, this study will provide useful insights on the risk factors for severe disease, clinical presentation, and outcomes of various cardiovascular manifestations in COVID-19 patients particularly from low and middle income countries from where the data remain scant.
Keywords: COVID-19; HIV; cardiovascular disease; chagas disease; cohort; coronavirus; registry; rheumatic heart disease; survey.
Conflict of interest statement
The authors have no competing interests to declare.
Copyright: © 2021 The Author(s).
Figures
References
- World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. 2020. Retrieved from: .
- Verity R, et al. Estimates of the severity of coronavirus disease 2019: A model-based analysis. The Lancet Infectious Diseases. 2020; 20(6): 669–677. DOI: 10.1016/S1473-3099(20)30243-7
- Chakafana G, et al. Interplay of COVID-19 and cardiovascular diseases in Africa: An observational snapshot. Clinical Research in Cardiology. 2020. DOI: 10.1007/s00392-020-01720-y
- Thienemann F, et al. World Heart Federation Briefing on Prevention: Coronavirus Disease 2019 (COVID-19) in Low-Income Countries. Global Heart. 2020; 15(1): 31–31. DOI: 10.5334/gh.778
- Prabhakaran D, et al. Management of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource Settings. Global Heart. 2020; 15(1): 44–44. DOI: 10.5334/gh.823
- Li B, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clinical Research in Cardiology. 2020; 109(5): 531–538. DOI: 10.1007/s00392-020-01626-9
- Yang X, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 2020; 8(5): 475–481. DOI: 10.1016/S2213-2600(20)30079-5
- Xiong T-Y, et al. Coronaviruses and the cardiovascular system: Acute and long-term implications. European heart journal. 2020; 41(19): 1798–1800. DOI: 10.1093/eurheartj/ehaa231
- Shi S, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiology. 2020; 5(7): 802–810. DOI: 10.1001/jamacardio.2020.0950
- Bank W. Poverty and Shared Prosperity 2020: Reversals of Fortune. 2020.
- Bukhman G, et al. The Lancet NCDI Poverty Commission: bridging a gap in universal health coverage for the poorest billion. The Lancet. 2020; 396(10256): 991–1044. DOI: 10.1016/S0140-6736(20)31907-3
- Sliwa K, Yacoub M. Catalysing the response to NCDI Poverty at a time of COVID-19. Lancet (London, England). 2020; 396(10256): 941–943. DOI: 10.1016/S0140-6736(20)31911-5
- Sliwa K. Heart failure can affect everyone: The ESC Geoffrey Rose lecture. European Heart Journal. 2020; 41(12): 1298–1306. DOI: 10.1093/eurheartj/ehaa084
- Harris PA, et al. Research electronic data capture (REDCap)–A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009; 42(2): 377–81. DOI: 10.1016/j.jbi.2008.08.010
- Harris PA, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019; 95: 103208. DOI: 10.1016/j.jbi.2019.103208
- Alkmim MB, et al. Brazilian National Service of Telediagnosis in Electrocardiography. Stud Health Technol Inform. 2019; 264: 1635–1636.
- Zakeri R, et al. A case-control and cohort study to determine the relationship between ethnic background and severe COVID-19. EClinicalMedicine.
Source: PubMed